A comprehensive view of Biogen Idec Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

FDA approves Sandoz's natalizumab-sztn biosimilar injection to treat adults with multiple sclerosis and Crohn disease, marking the first biosimilar to Biogen's natalizumab; the approval expected to increase patient access to effective treatments
Published: August 29, 2023 by HCPLive

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count